AU538653B2 - 7-(2-(2-amino thiazol-4-yl)-2-(carboxymethoxyimino) acetamioo)-3-(1-pyridiniammethyl)-ceph-3-em-4-carboxylate - Google Patents

7-(2-(2-amino thiazol-4-yl)-2-(carboxymethoxyimino) acetamioo)-3-(1-pyridiniammethyl)-ceph-3-em-4-carboxylate

Info

Publication number
AU538653B2
AU538653B2 AU62881/80A AU6288180A AU538653B2 AU 538653 B2 AU538653 B2 AU 538653B2 AU 62881/80 A AU62881/80 A AU 62881/80A AU 6288180 A AU6288180 A AU 6288180A AU 538653 B2 AU538653 B2 AU 538653B2
Authority
AU
Australia
Prior art keywords
pyridiniammethyl
acetamioo
carboxymethoxyimino
ceph
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU62881/80A
Other versions
AU6288180A (en
Inventor
David George Hubert Livermore
Christopher Earle Newall
Cynthia Hilda O:callaghan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU6288180A publication Critical patent/AU6288180A/en
Application granted granted Critical
Publication of AU538653B2 publication Critical patent/AU538653B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62881/80A 1979-10-02 1980-10-01 7-(2-(2-amino thiazol-4-yl)-2-(carboxymethoxyimino) acetamioo)-3-(1-pyridiniammethyl)-ceph-3-em-4-carboxylate Ceased AU538653B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7934069 1979-10-02
GB7934069 1979-10-02

Publications (2)

Publication Number Publication Date
AU6288180A AU6288180A (en) 1981-04-09
AU538653B2 true AU538653B2 (en) 1984-08-23

Family

ID=10508218

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62881/80A Ceased AU538653B2 (en) 1979-10-02 1980-10-01 7-(2-(2-amino thiazol-4-yl)-2-(carboxymethoxyimino) acetamioo)-3-(1-pyridiniammethyl)-ceph-3-em-4-carboxylate

Country Status (10)

Country Link
JP (1) JPS5657790A (en)
AU (1) AU538653B2 (en)
BE (1) BE885487A (en)
CH (1) CH645906A5 (en)
DE (1) DE3037101A1 (en)
FR (1) FR2466468A1 (en)
GB (1) GB2062624B (en)
IT (1) IT1143007B (en)
NL (1) NL8005440A (en)
ZA (1) ZA806084B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58210093A (en) * 1982-05-20 1983-12-07 グラクソ・グル−プ・リミテツド Cephalosporin antibiotic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522140A (en) * 1974-12-20 1978-08-23 Glaxo Lab Ltd Syn-7-(2-hydroxyiminoacetamido)-3-pyridiniummethyl cephalosporins methods for their preparation and compositions containing them
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (en) * 1977-03-25 1985-06-10 Roussel Uclaf SET TO MAKE NEW OXIME DERIVATIVES OF 3-ACETOXIMETHYL-7-AMINOTIAZOLYLACETAMIDO CEPHALOSPORANIC ACID
DE2758001A1 (en) * 1977-12-24 1979-07-12 Hoechst Ag CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
AR229883A1 (en) * 1978-05-26 1983-12-30 Glaxo Group Ltd PROCEDURE FOR THE PREPARATION OF ANTIBIOTIC (6R, 7R) -7 - ((Z) -2- (2-AMINOTIAZOL-4-IL) -2- (2-CARBOXIPROP-2-OXIIMINO) -ACETAMIDO) -3- (1 -PIRIDINOMETIL) -CEF-3-EM-4-CARBOXYLATE

Also Published As

Publication number Publication date
BE885487A (en) 1981-04-01
GB2062624A (en) 1981-05-28
FR2466468A1 (en) 1981-04-10
IT8049784A0 (en) 1980-10-01
IT1143007B (en) 1986-10-22
AU6288180A (en) 1981-04-09
ZA806084B (en) 1982-05-26
GB2062624B (en) 1983-09-07
DE3037101A1 (en) 1981-04-16
JPS5657790A (en) 1981-05-20
CH645906A5 (en) 1984-10-31
FR2466468B1 (en) 1984-02-10
NL8005440A (en) 1981-04-06

Similar Documents

Publication Publication Date Title
AU539519B2 (en) 7(2-(2-aminothiazol-4-yl)-2(2-carboxyprop-2-oxyimino) acteamido)-3-(1-pyridiniumethyl)ceph 3-em-4-carboxylate
AU8849982A (en) Herbicidal 2-(alpha-chloromethylsulfonyl) pyridine- 1-oxides
AU6306180A (en) Syn-7-(2-amino-4-thiazolyl) methoxyimino-acetamido -3- acetoxymethyl-3-cephem-4-carboxylic acid
IL65737A (en) 7-(2-(2-aminothiazol-4-yl)-2-oxy-iminoacetamido)-3-(1-pyridinium)methyl)ceph-3-em-4-carboxylate derivatives and pharmaceutical compositions comprising them
AU554489B2 (en) N-(4-(3-aminopropyl)aminobutyl)-2-(omega-guanidino- fatty-acid-amido)-2-substituted ethanamides
JPS6425768A (en) 2-(2-amino-4-thiazolyl)-2-methoxyiminoacetic acid derivative and manufacture
IL71771A (en) Process for the preparation of 7-(2-(aminothiazolyl or aminothiadiazolyl)2-hydroxyiminoacetamido)-3-(ammoniomethyl)-ceph-3-em-4-carboxylate derivatives
AU540382B2 (en) 7(2-(2-aminothiazol-4-yl)-2-(2-carboxy prop-2-oxyimino) acetamido)-3-(1-pyridiniummethyl) ceph-3-em-4-carboxylate
IT1149833B (en) 7- (2- (2-AMINO-4-THIAZOLYL) -2 - ((1-CARBOXY-1,1-DIALKYL) ALCOSSIIMMINO) ACETAMIDE) CEFEM SULPHOXIDES
ES519006A0 (en) PROCEDURE FOR PREPARING 2- (2-DIMETILAMINOETILTIO) -3-PENYLQUINOLINE.
IL72597A (en) 2-(3-carboxy-(hetero)aryl)-imidazolidinones and imidazolidinethiones,process for the preparation thereof,and use of said compounds as herbicidal agents
ES500076A0 (en) PERFECTED METHOD FOR THE MANUFACTURE OF 2- (3,4,5-TRIME-TOXIFENIL), 4,5-DISUBSTITUTED
AU507063B2 (en) 2-(n-cycloalkymethyl)-n-(phenyl)-amino)-2-imidazoline derivatives
NZ193682A (en) 2-(thiazol-2-yl)-3-hydroxycinnamonitrile cationic salts
GB2021561B (en) 3- substituted -7- (2 - (2- aminothiazol - 4-yl -2-(carboxymethoxyimino) - acetamidol) - cephalosporanic acid derivatives
AU6003780A (en) Thiazole derivatives
AU538653B2 (en) 7-(2-(2-amino thiazol-4-yl)-2-(carboxymethoxyimino) acetamioo)-3-(1-pyridiniammethyl)-ceph-3-em-4-carboxylate
NL191844C (en) Process for the preparation of sodium cefuroxime.
AU530911B2 (en) 2-(2-phenyl-6-benzothiazolyl) propionic acid
ES526275A0 (en) PROCEDURE FOR THE PREPARATION OF NEW 2-AMINO 5-AMINOMETIL 2-OXAZOLINES
IT7927106A0 (en) PROCEDURE FOR PREPARING 2-(4'HYDROXYARYL)-2-(4'AMMINOARYL)PROPANES.
ES498144A0 (en) PROCEDURE FOR PREPARING A 3-ACILAMINO-5- (4- (O 3) -PIRI-DINIL) -2- (1H) -PIRIDINONE
ZA791831B (en) 7-(2-(omega-(1,3-dithiolan-2-imino)substituted)acetylamino)cephalosporanic acid derivatives
AU537415B2 (en) 5-substituted oxazolidines
AU534572B2 (en) 6b-(2-(2:-methylphenorgcarbonyl)-2-thien-3:-ylacetamido)